198 related articles for article (PubMed ID: 34408160)
1. Exploring human-genome gut-microbiome interaction in Parkinson's disease.
Wallen ZD; Stone WJ; Factor SA; Molho E; Zabetian CP; Standaert DG; Payami H
NPJ Parkinsons Dis; 2021 Aug; 7(1):74. PubMed ID: 34408160
[TBL] [Abstract][Full Text] [Related]
2. Metagenomics of Parkinson's disease implicates the gut microbiome in multiple disease mechanisms.
Wallen ZD; Demirkan A; Twa G; Cohen G; Dean MN; Standaert DG; Sampson TR; Payami H
Nat Commun; 2022 Nov; 13(1):6958. PubMed ID: 36376318
[TBL] [Abstract][Full Text] [Related]
3. Nigral overexpression of α-synuclein in a rat Parkinson's disease model indicates alterations in the enteric nervous system and the gut microbiome.
O'Donovan SM; Crowley EK; Brown JR; O'Sullivan O; O'Leary OF; Timmons S; Nolan YM; Clarke DJ; Hyland NP; Joyce SA; Sullivan AM; O'Neill C
Neurogastroenterol Motil; 2020 Jan; 32(1):e13726. PubMed ID: 31576631
[TBL] [Abstract][Full Text] [Related]
4. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.
Wallen ZD; Appah M; Dean MN; Sesler CL; Factor SA; Molho E; Zabetian CP; Standaert DG; Payami H
NPJ Parkinsons Dis; 2020; 6():11. PubMed ID: 32566740
[TBL] [Abstract][Full Text] [Related]
5. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: Relevance to idiopathic Parkinson's disease.
Ilieva NM; Wallen ZD; De Miranda BR
Toxicol Appl Pharmacol; 2022 Sep; 451():116176. PubMed ID: 35914559
[TBL] [Abstract][Full Text] [Related]
6. α-Synuclein Overexpression and the Microbiome Shape the Gut and Brain Metabolome in Mice.
Morais LH; Boktor JC; MahmoudianDehkordi S; Kaddurah-Daouk R; Mazmanian SK
bioRxiv; 2024 Jun; ():. PubMed ID: 38915679
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
8. Implications of the Gut Microbiome in Parkinson's Disease.
Elfil M; Kamel S; Kandil M; Koo BB; Schaefer SM
Mov Disord; 2020 Jun; 35(6):921-933. PubMed ID: 32092186
[TBL] [Abstract][Full Text] [Related]
9. The Gut and Parkinson's Disease-A Bidirectional Pathway.
Santos SF; de Oliveira HL; Yamada ES; Neves BC; Pereira A
Front Neurol; 2019; 10():574. PubMed ID: 31214110
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.
Dutta SK; Verma S; Jain V; Surapaneni BK; Vinayek R; Phillips L; Nair PP
J Neurogastroenterol Motil; 2019 Jul; 25(3):363-376. PubMed ID: 31327219
[TBL] [Abstract][Full Text] [Related]
11. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
Chiang HL; Lin CH
J Mov Disord; 2019 May; 12(2):67-83. PubMed ID: 31158941
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease and the gastrointestinal microbiome.
Lubomski M; Tan AH; Lim SY; Holmes AJ; Davis RL; Sue CM
J Neurol; 2020 Sep; 267(9):2507-2523. PubMed ID: 31041582
[TBL] [Abstract][Full Text] [Related]
13. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
Rani L; Mondal AC
Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
[TBL] [Abstract][Full Text] [Related]
14. Environmental neurotoxicants and inflammasome activation in Parkinson's disease - A focus on the gut-brain axis.
Johnson AM; Ou ZA; Gordon R; Saminathan H
Int J Biochem Cell Biol; 2022 Jan; 142():106113. PubMed ID: 34737076
[TBL] [Abstract][Full Text] [Related]
15. The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?
Killinger B; Labrie V
J Parkinsons Dis; 2019; 9(s2):S345-S358. PubMed ID: 31609697
[TBL] [Abstract][Full Text] [Related]
16. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
[TBL] [Abstract][Full Text] [Related]
17. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson's Disease.
Baizabal-Carvallo JF; Alonso-Juarez M
Neuroscience; 2020 Apr; 432():160-173. PubMed ID: 32112917
[TBL] [Abstract][Full Text] [Related]
18. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V; Giron MC
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
[TBL] [Abstract][Full Text] [Related]
19. Oral and gut dysbiosis leads to functional alterations in Parkinson's disease.
Jo S; Kang W; Hwang YS; Lee SH; Park KW; Kim MS; Lee H; Yoon HJ; Park YK; Chalita M; Lee JH; Sung H; Lee JY; Bae JW; Chung SJ
NPJ Parkinsons Dis; 2022 Jul; 8(1):87. PubMed ID: 35798742
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
